Extracorporeal shockwave therapy uses shock waves to help with healing, pain reduction, and repair processes. It is a noninvasive treatment option for various conditions that affect the ...

Methylene blue significantly shortened time to shock reversal and length of stay in the intensive care unit, based on data from nearly 100 individuals. Although methylene blue is often used to treat ...

Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. In this multicenter trial, ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic shock and hemorrhagic ...

Cardiogenic shock (CS) can happen with advanced heart failure – when your heart can’t pump enough blood to meet your body’s needs. It’s a potentially deadly medical emergency, and you’ll need ...

Hemorrhagic shock can occur after losing a significant amount of blood. Both internal and external bleeding can cause it. Hemorrhagic shock is life threatening and requires immediate medical attention ...

Windtree Therapeutics, Inc. WINT, a biotechnology company treating late-stage acute cardiovascular disorders, is advancing its first-in-class drug for serious heart conditions. The company believes ...

PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm ...